Avalyn Pharma logo

Avalyn Pharma Funding & Investors

Seattle, WA

Avalyn Pharma Inc. operates as a pharmaceutical company. The Company develops treatments for Idiopathic Pulmonary Fibrosis (IPF).

avalynpharma.com

Total Amount Raised: $436,679,488

Avalyn Pharma Funding Rounds

  • Series D

    $100,000,000

    Series D Investors

    Sr One
    Suvretta Capital Management
    Pivotal bioVenture Partners
    TPG Biotech
    Wellington Management
    Eventide
    Surveyor Capital
    F-Prime Capital
    RiverVest Venture Management
    Norwest Venture Partners
    Rock Springs Capital
    Vida Ventures
    Catalio Capital Management
    Perceptive Advisors
    Novo Holdings
    Hamilton Square Partners Management
    T. Rowe Price
    Piper Heartland Healthcare Capital

  • Series C

    $175,000,000

    Series C Investors

    Eventide
    Perceptive Advisors
    Sr One
    Wellington Management
    Catalio Capital Management
    Piper Heartland Healthcare Capital
    Vida Ventures
    Pivotal bioVenture Partners
    Surveyor Capital
    Rock Springs Capital
    RiverVest Venture Management
    Norwest Venture Partners
    F-Prime Capital
    Novo Holdings

  • Series B

    $35,500,000

    Series B Investors

    Norwest Venture Partners
    F-Prime Capital
    Pivotal bioVenture Partners
    TPG Biotech
    RiverVest Venture Management
    Novo Holdings

  • Series A

    $62,000,000

    Series A Investors

    Andera Partners
    F-Prime Capital
    Novo Holdings
    RiverVest Venture Management
    TPG Biotech

  • Series A

    $62,000,000

    Series A Investors

    Eight Roads
    Andera Partners
    RiverVest Venture Management
    TPG Biotech
    F-Prime Capital
    Novo Holdings
    Edmond de Rothschild Suisse

  • Seed

    $2,179,480

Funding info provided by Diffbot.